No effects of atorvastatin (10mg/d or 80mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study by Tsikas, Dimitrios, Pham, Vu Vi, Suchy, Maria-Theresia, van de Ree, Marcel A., Huisman, Menno V., Frölich, Jürgen C., Princen, Hans M.G.

Get full text

Plasma pre β-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein by Dallinga-Thie, G.M., van Tol, A., Dullaart, R.P.F.

Get full text

The changing treatment paradigm in prolactinoma - a prospective series of 100 consecutive neurosurgical cases by van Trigt, Victoria R, Bakker, Leontine E H, Pelsma, Iris C M, Zandbergen, Ingrid M, Jentus, Maaia M, Kruit, Mark C, Dekkers, Olaf M, van Furth, Wouter R, Verstegen, Marco J T, Biermasz, Nienke R

Get full text

Statins in type 2 diabetes mellitus: target on lipids and vascular wall function by van de Ree, M A, van Venrooij, F V, Meinders, A E, Jonkers, I J A M, Berk-Planken, I, Huisman, M V

Get full text

Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus by van de Ree, M.A, Huisman, M.V, Princen, H.M.G, Meinders, A.E, Kluft, C

Get full text

The effect of aggressive versus standard doses of atorvastatin on diabetic dyslipidemia: the dali study by van de Ree, M.A., van Venrooij, F.V., Berk-Planken, I., Stolk, R.P.

Get full text